B. Levine

Oncology · 2011–2022

A researcher in the Science corpus: 22 papers; trusts 2 researchers and is trusted by 9 researchers here, as inferred from the citation graph.

Subfields

Whom B. Levine trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Porter

Who trusts B. Levine overall

  1. Jennifer N. Brudno
  2. J. Kochenderfer
  3. S. Maude
  4. Kole T. Roybal
  5. D. Porter
  6. D. Teachey
  7. C. June
  8. N. Shah
  9. N. Restifo
  10. Wendell A. Lim

Papers from B. Levine's perspective

Ordered by how strongly the researchers B. Levine trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.
  2. Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells (Clinical Cancer Research)
  3. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (New England Journal of Medicine)
  4. A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer (Clinical Cancer Research)
  5. Cancer regression and neurologic toxicity following anti-MAGE-A3 TCR gene therapy (Journal of immunotherapy)
  6. Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate… (Journal of Clinical Oncology)
  7. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia (Nature)
  8. Immunological aspects of cancer chemotherapy (Nature reviews. Immunology)
  9. HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma (JAMA Oncology)
  10. Cancer/testis antigens, gametogenesis and cancer (Nature Reviews. Cancer)

Their papers